You are viewing the site in preview mode
Skip to main content
|
Patient
|
Age
|
Pharmacological therapy
|
Initial assessment
|
Final evaluation
|
|---|
|
UPDRS (III) score
|
H&Y
|
Mini-BEST test
|
PDQ-39
|
UPDRS (III) score
|
H&Y
|
Mini-BEST test
|
|---|
|
A
|
71
|
Stalevo, Sirio, Sinem et
|
Limbs’s rigidity (2) sn>dx; remarkable postural instability (3)
|
3
|
13/28
|
21%
|
Limbs’s rigidity (1) sn>dx; remarkable postural instability (1)
|
3
|
20/28
|
|
B
|
80
|
Azilect, Sinem et
|
Very important rigidity & tremor to the right (3) postural instability (2)
|
3
|
18/28
|
18%
|
Rigidity dx (2) postural instability (1)
|
3
|
21/28
|
|
C
|
63
|
Azilect, Sinem et
|
Limbs’s rigidity (1) hand gesture deficit (2)
|
1.5
|
27/28
|
5%
|
Limbs’s rigidity (1) hand gesture deficit (1)
|
1.5
|
28/28
|
|
D
|
67
|
Madopal, Azilet, Mirapexil
|
Deambulation (1) Evident postural instability (3)
|
2.5
|
22/28
|
10%
|
Deambulation (1) Evident postural instability (1)
|
2.5
|
25/28
|